|
1
|
Ogurtsova K, da Rocha Fernandes JD, Huang
Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE and
Markaroff LE: IDF Diabetes Atlas: Global estimates for the
prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract.
128:40–50. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Akash MSH, Rehman K and Liaqat A: Tumor
necrosis factor-alpha: Role in development of insulin resistance
and pathogenesis of type 2 diabetes mellitus. J Cell Biochem.
119:105–110. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rehman K, Akash MSH, Liaqat A, Kamal S,
Qadir MI and Rasul A: Role of interleukin-6 in development of
insulin resistance and type 2 diabetes mellitus. Crit Rev Eukaryot
Gene Expr. 27:229–236. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ku CR, Lee HJ, Kim SK, Lee EY, Lee MK and
Lee EJ: Resveratrol prevents streptozotocin-induced diabetes by
inhibiting the apoptosis of pancreatic β-cell and the cleavage of
poly (ADP-ribose) polymerase. Endocr J. 59:103–109. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Q, Yue Y, Chen L, Xu C, Wang Y, Du L,
Xue X, Liu Q, Wang Y and Fan F: Resveratrol sensitizes
carfilzomib-induced apoptosis via promoting oxidative stress in
multiple myeloma cells. Front Pharmacol. 9:3342018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu X, Wu C, Qiu S, Yuan X and Li L:
Effects of resveratrol on glucose control and insulin sensitivity
in subjects with type 2 diabetes: Systematic review and
meta-analysis. Nutr Metab (Lond). 14:602017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abbasi Oshaghi E, Goodarzi MT, Higgins V
and Adeli K: Role of resveratrol in the management of insulin
resistance and related conditions: Mechanism of action. Crit Rev
Clin Lab Sci. 54:267–293. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao H, Shu L, Huang W, Song G and Ma H:
Resveratrol affects hepatic gluconeogenesis via histone deacetylase
4. Diabetes Metab Syndr Obes. 12:401–411. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hang Z, Yunjia Z, Linyi S, Guangyao S and
Huijuan M: Resveratrol reduces liver endoplasmic reticulum stress
and improves insulin sensitivity in vivo and in vitro. Drug Des Dev
Ther. 13:1473–1485. 2019. View Article : Google Scholar
|
|
10
|
Wang X, Chang X, Zhang P, Fan L, Zhou T
and Sun K: Aberrant expression of long non-coding RNAs in newly
diagnosed type 2 diabetes indicates potential roles in chronic
inflammation and insulin resistance. Cell Physiol Biochem.
43:2367–2378. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao Y, Wu F, Zhou J, Yan L, Jurczak MJ,
Lee HY, Yang L, Mueller M, Zhou XB, Dandolo L, et al: The H19/let-7
double-negative feedback loop contributes to glucose metabolism in
muscle cells. Nucleic Acids Res. 42:13799–13811. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shu L, Zhao H, Huang W, Hou G, Song G and
Ma H: Resveratrol Upregulates mmu-miR-363-3p via the PI3K-Akt
pathway to improve insulin resistance induced by a high-fat diet in
mice. Diabetes Metab Syndr Obes. 13:391–403. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Buchfink B, Xie C and Huson DH: Fast and
sensitive protein alignment using DIAMOND. Nat Methods. 12:59–60.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zou Q, Mao Y, Hu L, Wu Y and Ji Z:
miRClassify: An advanced web server for miRNA family classification
and annotation. Comput Biol Med. 45:157–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang H, Ge Z, Tang S, Meng R, Bi Y and
Zhu D: Erythropoietin ameliorates PA-induced insulin resistance
through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and
inhibits the inflammatory response in HepG2 cells. Mol Med Rep.
16:2295–2301. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shu L, Hou G, Zhao H, Huang W, Song G and
Ma H: Resveratrol improves high-fat diet-induced insulin resistance
in mice by downregulating the lncRNA NONMMUT008655.2. Am J Transl
Res. 12:1–18. 2020.PubMed/NCBI
|
|
19
|
Li B and Dewey C: RSEM: Accurate
transcript quantification from RNA-Seq data with or without a
reference genome. BMC Bioinformatics. 12:3232011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Grabherr MG, Haas BJ, Yassour M, Levin JZ,
Thompson DA, Amit I, Adiconis X, Fan L, Raychowdhury R, Zeng Q, et
al: Trinity: Reconstructing a full-length transcriptome without a
genome from RNA-Seq data. Nat Biotechnol. 29:644–652. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brasnyó P, Molnár GA, Mohás M, Markó L,
Laczy B, Cseh J, Mikolás E, Szijártó IA, Mérei A, Halmai R, et al:
Resveratrol improves insulin sensitivity, reduces oxidative stress
and activates the Akt pathway in type 2 diabetic patients. Br J
Nutr. 106:383–389. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thiel G and Rössler OG: Resveratrol
regulates gene transcription via activation of stimulus-responsive
transcription factors. Pharmacol Res. 117:166–176. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rezaei Farimani A, Goodarzi MT, Saidijam
M, Yadegarazari R, Zarei S and Asadi S: Effect of resveratrol on
SNARE proteins expression and insulin resistance in skeletal muscle
of diabetic rats. Iran J Basic Med Sci. 22:1408–1414.
2019.PubMed/NCBI
|
|
24
|
Kim J, Bilder D and Neufeld TP: Mechanical
stress regulates insulin sensitivity through integrin-dependent
control of insulin receptor localization. Genes Dev. 32:156–164.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hatting M, Tavares CDJ, Sharabi K, Rines
AK and Puigserver P: Insulin regulation of gluconeogenesis. Ann N Y
Acad Sci. 1411:21–35. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Langlet F, Haeusler RA, Lindén D, Ericson
E, Norris T, Johansson A, Cook JR, Aizawa K, Wang L, Buettner C and
Accili D: Selective inhibition of FOXO1 activator/repressor balance
modulates hepatic glucose handling. Cell. 171:824–835.e18. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McCurdy CE, Schenk S, Holliday MJ, Philip
A, Houck JA, Patsouris D, MacLean PS, Majka SM, Klemm DJ and
Friedman JE: Attenuated Pik3r1 expression prevents insulin
resistance and adipose tissue macrophage accumulation in
diet-induced obese mice. Diabetes. 61:2495–505. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma Z, Gong Y, Patel V, Karner CM, Fischer
E, Hiesberger T, Carroll TJ, Pontoglio M and Igarashi P: Mutations
of HNF-1beta inhibit epithelial morphogenesis through dysregulation
of SOCS-3. Proc Natl Acad Sci USA. 104:20386–20391. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Galic S, Sachithanandan N, Kay TW and
Steinberg GR: Suppressor of cytokine signalling (SOCS) proteins as
guardians of inflammatory responses critical for regulating insulin
sensitivity. Biochem J. 461:177–188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fang S, Feng J, Zhang H, Li P, Zhang Y,
Zeng Y, Cai Y, Lin X, Xue Y and Guan M: MiR-455 targeting SOCS3
improve liver lipid disorders in diabetic mice. Adipocyte.
9:179–188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pedroso JA, Buonfiglio DC, Cardinali LI,
Furigo IC, Ramos-Lobo AM, Tirapegui J, Elias CF and Donato J Jr:
Inactivation of SOCS3 in leptin receptor-expressing cells protects
mice from diet-induced insulin resistance but does not prevent
obesity. Mol Metab. 3:608–618. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Abo El-Nasr NME, Saleh DO, Mahmoud SS,
Nofal SM, Abdelsalam RM, Safar MM and El-Abhar HS: Olmesartan
attenuates type 2 diabetes-associated liver injury: Cross-talk of
AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways. Eur J
Pharmacol. 874:1730102020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Terán-Cabanillas E and Hernández J: Role
of leptin and SOCS3 in inhibiting the type I interferon response
during obesity. Inflammation. 40:58–67. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong C, Liu S, Li Y and Cui Y: Serum
lncRNA HAND2-AS1 is downregulated in diabetic patients with chronic
renal failure and ameliorates cell apoptosis. Diabetol Metab Syndr.
12:392020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sathishkumar C, Prabu P, Mohan V and
Balasubramanyam M: Linking a role of lncRNAs (long non-coding RNAs)
with insulin resistance, accelerated senescence, and inflammation
in patients with type 2 diabetes. Hum Genomics. 12:412018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao H, Chen S, Gao K, Zhou Z, Wang C,
Shen Z, Guo Y, Li Z, Wan Z, Liu C and Mei X: Resveratrol protects
against spinal cord injury by activating autophagy and inhibiting
apoptosis mediated by the SIRT1/AMPK signaling pathway.
Neuroscience. 348:241–251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
González-Rodríguez Á, Santamaría B,
Mas-Gutierrez JA, Rada P, Fernández-Millán E, Pardo V, Álvarez C,
Cuadrado A, Ros M, Serrano M and Valverde AM: Resveratrol treatment
restores peripheral insulin sensitivity in diabetic mice in a
sirt1-independent manner. Mol Nutr Food Res. 59:1431–1442. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ren XY, Han YD and Lin Q: Long non-coding
RNA MIR155HG knockdown suppresses cell proliferation, migration and
invasion in NSCLC by upregulating TP53INP1 directly targeted by
miR-155-3p and miR-155-5p. Eur Rev Med Pharmacol Sci. 24:4822–4835.
2020.PubMed/NCBI
|
|
41
|
Chen K, Ma Y, Wu S, Zhuang Y, Liu X, Lv L
and Zhang G: Construction and analysis of a lncRNA-miRNA-mRNA
network based on competitive endogenous RNA reveals functional
lncRNAs in diabetic cardiomyopathy. Mol Med Rep. 20:1393–1403.
2019.PubMed/NCBI
|
